Oppenheimer Downgrades Sunshine Heart (SSH) to Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Sunshine Heart (SSH) PT Cut to $4 as Clinical Trials Stopped - Piper Jaffray
March 4, 2016 8:14 AM ESTPiper Jaffray analyst, Thomas Gunderson, maintained his Overweight rating but cut his PT to $4 from $10 on Sunshine Heart (NASDAQ: SSH) as clinical trials ceased to conserve cash. The analyst thinks SSH is taking a step back to increase the chances that the... More
